» Articles » PMID: 12702514

Effect of a Comprehensive Clinical Care Program on Disease Course in Severely Ill Children with Sickle Cell Anemia in a Sub-Saharan African Setting

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2003 Apr 19
PMID 12702514
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical severity of sickle cell anemia (SS) in Africa may not be solely determined by genetic factors. This study evaluated the effects of intensive parental education and adequate clinical care on the course of SS in children in Benin. SS children referred to the National Teaching Hospital in Cotonou were included in the study. Teaching about SS was repeated frequently, emphasizing the importance of keeping clinic appointments, improving the nutrition of the affected children, and instituting antipneumococcal and antimalarial prophylaxis. Frequency and severity of SS-related events, changes in physical growth, frequency of malarial attacks, causes of transfusion, and causes of death were the principal variables assessed. 236 young children with repeated SS-related acute complications were studied from July 1, 1993, to December 31, 1999 (983 patient-years). A marked reduction in the frequency and severity of SS-related acute events was observed. Improvement in general status and physical growth was noted in 184 patients (78%); in addition, 22 of the remaining 52 patients showed similar improvement after remotivating the parents for compliance. There were 10 deaths, primarily in this cohort of 52 patients. Intensive sociomedical intervention can produce sustained clinical improvement in many severely ill SS children in sub-Saharan Africa.

Citing Articles

[Blood count abnormalities in the association of sickle cell disease and malaria in clinical hematology at the CNHU-HKM in Cotonou (Bénin)].

Zohoun A, Bagloagbodande T, Adanho A, Massi R, Houssou B, Orou Guiwa G Med Trop Sante Int. 2024; 4(1).

PMID: 38846115 PMC: 11151902. DOI: 10.48327/mtsi.v4i1.2024.404.


Epidemiological and clinical characteristics of 66 Tunisian Sickle cell syndrome patients.

Sahli A, Ouali F, Dabboubi R, Hadj Fredj S, Meddeb N, Mzoughi N Afr Health Sci. 2024; 23(3):213-222.

PMID: 38357153 PMC: 10862594. DOI: 10.4314/ahs.v23i3.26.


Evidence-based interventions for reducing sickle cell disease-associated morbidity and mortality in sub-Saharan Africa: A scoping review.

Arji E, Eze U, Ezenwaka G, Kennedy N SAGE Open Med. 2023; 11:20503121231197866.

PMID: 37719166 PMC: 10504846. DOI: 10.1177/20503121231197866.


A Critical Review of Sickle Cell Disease Burden and Challenges in Sub-Saharan Africa.

Adigwe O, Onoja S, Onavbavba G J Blood Med. 2023; 14:367-376.

PMID: 37284610 PMC: 10239624. DOI: 10.2147/JBM.S406196.


Bacterial Infection in the Sickle Cell Population: Development and Enabling Factors.

Delicat-Loembet L, Baraika M, Bougoudogo F, Diallo D Microorganisms. 2023; 11(4).

PMID: 37110283 PMC: 10142700. DOI: 10.3390/microorganisms11040859.